Anika Therapeutics

NASDAQ
ANIK
Stock
Yield per half year: -37.89%
Dividend yield: 0%
Sector: Healthcare

Reporting Anika Therapeutics

Reports

IFRS
Reporting Annual Quarterly
2016 2017 2018 2019 2020 2021 2022 2023
Financial report link link link link link link link link


Capitalization

IFRS
Reporting Annual Quarterly
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 LTM Average for 5 years CAGR 5
Capitalization, bln $
0.6111 0.5724 0.7344 0.7547 0.4705 0.643 0.516 0.4466 0.4116 0.2752 0.4975 -2.64
Revenue, bln $
0.103 0.113 0.106 0.115 0.1305 0.1478 0.1562 0.1667 0.1199 0.1199 0.1442 -1.68
Net profit, bln $
0.033 0.032 0.019 0.027 -0.024 0.0041 -0.0149 -0.0827 -0.0564 -0.0564 -0.0348 18.64
EV, bln $
0.594 0.628 0.326 0.57 0.567 0.443 0.3507 0.2977 0.2095 0.2095 0.3736 -18.06
EBIT, bln $
0.0506 0.0457 0.0217 0.0342 -0.0145 -0.0185 -0.0194 -0.0254 -0.0051 -0.0051 -0.0166 -18.86
EBITDA, bln $
0.054 0.05 0.028 0.04 -0.0152 0.0166 -0.0049 -0.0112 0.003 0.003 -0.0023 -172.29
OIBDA $
-0.0033 -0.02 -0.0095 -0.0162 0.0543 0.0543 0.0011 -275.09
Book value, bln $
0.1682 0.1995 0.247 0.273 0.173 0.197 0.2856 0.2123 0.154 0.154 0.2044 -2.30
FCF, bln $
0.01 0.032 0.03 0.034 0.0114 0.0033 -0.0031 -0.0072 -0.0023 -0.0023 0.0004 -172.60
Operating Cash Flow, bln $
0.0238 0.0408 0.0349 0.037 0.0131 0.0084 0.0044 -0.0018 0.0054 0.0054 0.0059 -16.24
Operating profit, bln $
0.051 0.046 0.022 0.034 -0.014 0.0026 -0.0194 -0.0876 -0.0051 -0.0051 -0.0247 -18.29
Operating expenses, bln $
0.0287 0.0403 0.0525 0.0516 0.0835 0.1014 0.113 0.1915 0.0811 0.0811 0.1141 -0.58
CAPEX, bln $
0.014 0.009 0.005 0.003 0.0016 0.0051 0.0075 0.0054 0.0077 0.0077 0.0055 36.92


Balance sheet

IFRS
Reporting Annual Quarterly
2007 2008 2009 2010 2011 2012 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 LTM Average for 5 years CAGR 5
Cash, bln $
0.1043 0.1573 0.159 0.1849 0.0983 0.0944 0.0863 0.0729 0.0556 0.0556 0.0815 -10.77
Short-Term Investments $
0.0035 0.0068 0.0278 0.0205 0.024 0.07 0.0275 0.0025 0.0346 0.0346 0.0317 7.59
Accounts Receivable $
0.0276 0.0238 0.0208 0.0231 0.0241 0.0298 0.0346 0.036 0.0236 0.0236 0.0296 -0.42
Total Current Assets $
0.1704 0.2063 0.2068 0.2357 0.1774 0.1685 0.1695 0.1633 0.1137 0.1137 0.1585 -8.51
Net assets, bln $
0.2108 0.2228 0.2635 0.2636 0.2884 0.2724 0.2871 0.0483 0.2776 0.0483 0.2348 -0.76
Assets, bln $
0.2402 0.2826 0.279 0.3307 0.3656 0.3475 0.3491 0.2706 0.2027 0.2027 0.3071 -11.13
Short-Term Debt $
0.0016 0.0001 0.0000 0.0011 0.0016 0.0017 0.0021 0.0021 0.0019 0.0019 0.0019 3.50
Long-Term Debt $
0.0144 0.0128 0.0112 0.0096 0.008 0.0112 -11.09
Liabilities, bln $
0.0175 0.0191 0.0154 0.0423 0.0932 0.0605 0.0636 0.0584 0.0488 0.0488 0.0649 -12.14
Net debt, bln $
-0.1043 -0.1333 -0.159 -0.1624 -0.0759 -0.0734 -0.0554 -0.0438 -0.0297 -0.0297 -0.0556 -17.11
Debt, bln $
0 0 0 0.0225 0.0225 0.021 0.0309 0.029 0.0259 0.0259 0.0259 2.85
Interest Income $
0.00012 0.000263 0.000473 0.0015 0.0019 0.0009 73.75
Interest Expense, bln $
0.000263 0.000473 0.0015 0.0019 0.000302 0.000188 0.000654 0.0023 0.0023 0.0023 0.0011 50.09
Net interest income, bln $
0.000263 0.000473 0.0015 0.0019 -0.000302 -0.000188 0.000654 0.002 0.0008 1.03
Goodwill $
0.0083 0.0075 0.0072 0.0082 0.0079 0.0077 0.0084 0.0078 0.0073 0.0076 0.0078 -0.26
Amortization, bln $
0.0037 0.0043 0.0059 0.006 0.0139 -0.0211 0.0145 0.0142 0.0081 0.0081 0.0059 -10.24
Cost of production, bln $
0.024 0.0274 0.0313 0.0287 0.0614 0.0649 0.0627 0.0636 0.0439 0.0439 0.0593 -6.49
Inventory $
0.016 0.022 0.0251 0.022 0.0462 0.036 0.0398 0.0464 0.0238 0.0238 0.0384 -12.42


Share

IFRS
Reporting Annual Quarterly
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 LTM Average for 5 years CAGR 5
EPS 2.15 2.11 1.27 1.89 -1.69 0.28 -1.02 -5.64 -3.83 -3.83 -2.3800 17.78
Share price 48.96 53.91 33.61 51.85 45.26 30.57 22.66 16.46 11.08 11.08 25.21 -24.53
Number of shares, mln 15 15 14 14 14 14 14.56 14.66 14.72 14.72 14.39 1.01
FCF/share 0.6525 2.12 2.06 2.38 0.8042 0.2288 -0.2113 -0.4923 -0.1583 -0.1583 0.0342 -172.25


Efficiency

IFRS
Reporting Annual Quarterly
2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 LTM Industry average Average for 5 years CAGR 5
ROE, % 15.01 13.09 7.1 9.85 -8.55 1.48 -5.19 -33.21 -30.79 -30.79 17.60 -15.2520 29.21
ROA, % 13.68 12.17 6.67 8.92 -6.89 1.16 -4.27 -26.68 -23.82 -23.82 5.71 -12.1000 28.16
ROIC, % 16.83 24.43 15.82 15.01 13.09 7.1 9.11 -7.92 1.37 -0.54 17.65 4.55 -36.33
ROS, % 40.74 21.99 31.52 -21.94 1.51 -9.51 -49.6 -47.02 -47.02 -47.02 13.36 -30.3280 -298.91
ROCE, % 17.36 8.12 10.89 -4.4 -5.82 -6.04 -10.62 -2.84 -3.31 -3.31 29.73 -5.7260 -10.67
EBIT margin 29.88 -21.33 -9.05 -12.42 -15.27 -4.25 -4.25 -4.25 18.53 -9.0480 -14.03
EBITDA margin 44.52 27.58 36.74 -11.62 -3.97 -3.14 -6.74 2.52 2.52 2.52 26.10 -1.7620 -191.31
Net margin 49 40.3 20.6 29.9 -11.1 -12.5 -9.51 -49.6 -47.02 -47.02 13.36 -25.9460 33.47
Operational efficiency, % 40.32 20.6 29.88 -11.09 1.77 -12.42 -52.58 -4.25 -4.25 -4.25 16.64 -14.3460 -219.15
Net interest margin, % 27.4 36.29 33.07 31.48 28.05 17.74 23.73 -18.38 2.8 -1.09 24.17 10.79 -36.93
FCF yield, % 6.71 4.88 1.71 4.33 4.67 5.4 2.22 0.5362 -0.7875 -1.97 1.08 -181.74


Coefficients

IFRS
Reporting Annual Quarterly
2011 2012 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 LTM Industry average Average for 5 years CAGR 5
P/E
20.8 21 25.4 26.5 24.1 -27.64 43 43 43 43 69.12 25.09 12.28
P/BV
3.3 3.1 1.9 2.6 2.3 1.8 1.42 1.61 1.55 1.55 8.87 1.74 -7.59
P/S
7.1 7.2 4.6 6.6 5.1 3.6 2.6 2.05 2 2 8.05 3.07 -17.07
P/FCF
24.81 16.27 22.22 57.96 158.98 -126.98 -88.77 -38.14 -118.06 -118.06 8.97 -42.5940 -194.22
E/P
0.0421 0.0289 0.043 -0.0465 0.0068 -0.038 -0.2253 -0.3004 -0.2049 -0.2049 0.03 -0.1524 -297.61
EV/EBIT
17.72 -20.44 -33.59 -18.08 -11.7 -41.07 -41.07 -41.07 88.11 -29.1020 4.10
EV/EBITDA
11.22 13.45 14.21 14.44 -37.62 -169.86 -71.38 -26.5 69.38 69.38 53.63 -47.1960 -213.02
EV/S
1.25 2.01 5.29 4.36 3.04 2.24 1.79 1.75 1.75 1.75 8.36 2.11 -10.46
EV/FCF
9.21 15.86 17.75 49.73 138.04 -113.96 -41.25 -89.88 -89.88 -89.88 21.77 -39.3860 -191.78
Debt/EBITDA
0.63 0.4 0.5345 -1.48 1.27 -6.29 -2.59 8.59 8.59 8.59 2.61 1.91 46.57
Netdebt/Ebitda
-2.64 -3.06 -3.71 6.22 -10.88 11.28 3.9 -9.83 -9.83 -9.83 0.49 -3.0720 -2.01
Debt/Ratio
0.07 0.06 0.13 0.25 0.17 0.0885 0.1073 0.1279 0.1279 0.1279 0.24 0.1243 -5.53
Debt/Equity
0.07 0.06 0.15 0.34 0.21 0.1082 0.1368 0.1684 0.3166 0.3166 2.82 0.1880 8.56
Debt/Net Income
1.32 0.8165 0.7858 -0.8706 4.65 -2.08 -0.3513 -0.4599 -0.4599 -0.4599 10.75 0.2598 -162.96
PEG
17.24 17.24 -67.37 17.24 0.00
Beta
1.15 0.92 1.71 -1.8 -1.01 -1.01 -0.03 0.1940 -197.44
Altman Index
27.52 21.79 13.3 5.68 -0.229 -1.07 1.02 1.24 0.6463 0.6463 12.59 0.3215 -223.06


Dividends

IFRS
Reporting Annual Quarterly
2009 2015 2016 2017 2018 2019 2020 2021 2022 2023 LTM Industry average Average for 5 years CAGR 5
Div. payout, bln
33.64 0.0013 0.000642 0.000253 0.000253 6.73 -90.55
Dividend
0
Dividend yield, %
0 0 0 0 0 0 0 0 0 0 1.71
Dividends / profit, %
912271.88 4.64 -5.26 15.53 0 0 0 155.02 228071.70 -93.58


Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

Subscribe

Other

IFRS
Reporting Annual Quarterly
2016 2017 2018 2019 2020 2021 2022 2023 2024 LTM CAGR 5
R&D, bln
0.0107 0.0188 0.0182 0.0167 0.0234 0.0273 0.0282 0.0327 0.0286 14.38
Total Debt
0.0113 0.0163 0.0369 48.36
CAPEX/Revenue, %
1.25 3.48 4.79 3.26 6.45 6.45 38.84
Staff, people
277 277 345 357 6.55